Last updated
CeQur: Capital Raising
CeQur, a medical device company developing wearable insulin-delivery patches for diabetes management, raised $100M in H1 2026 to support product scaling and market expansion.
Source: Tech.eu
- Who
- CeQur · Switzerland
- What happened
- CeQur, a medical device company developing wearable insulin-delivery patches for diabetes management, raised $100M in H1 2026 to support product scaling and market expansion.
- When
- 2026-09-24
- Source
- Tech.eu
- So what
- CeQur's raise resets the leadership agenda more than the balance sheet.
The leadership read
CeQur's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
Market context: The wider read — a Talent Market Index of 97.6 (Neutral), down 3.4 month-on-month — shows EMEA signal flow rising (+5.9pts).
CeQur: 2 signals in the last 90 days; 2 tracked across 47 days.
MitchelLake in this thematic
Also at CeQur →
More signals across EMEA
Capital Raising · EMEA
Harwood Private Capital →Harwood Private Capital received an additional £40m commitment from the British Business Bank, supporting the first close of Harwood Private Capital UK Fund II and bringing total committed capital to about £120m.
Capital Raising · EMEA
Nebuly →Turin-based Nebuly raised a $21m Series A led by Planven, with Exor Ventures, Tenacity Capital, TGVG Capital, Fastweb+Vodafone and CDP Venture Capital participating; it helps businesses measure financial return from AI agents.
Capital Raising · EMEA
AICertified →Irish AI training firm AICertified aims to raise up to €5m over the next year and operates in 15 countries, seeking to at least double that footprint.
Capital Raising · EMEA
EbonyLife Group →EbonyLife Group and Logical African Partners, the African investment vehicle of France's Logical Pictures, launched a $50 million Afro Film Fund to finance about 35 African films over eight years.
Capital Raising · EMEA
Zilch Technology →London-based Zilch expanded its debt facilities by £165m to a total of £395m, led by Deutsche Bank with participation from two large credit funds, to support lending of up to £6bn annually and its Pay Monthly product. Reports say it is preparing a potential £1.5bn London IPO.
Capital Raising · EMEA
Rem3dy Health →Birmingham-based Rem3dy Health received an undisclosed strategic investment from Hikma Ventures, the corporate venture arm of Hikma Pharmaceuticals, alongside an exclusive commercial partnership. Revenue grew 61% to £10.2m.
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Executive Search: EMEA →
Our EMEA practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record